This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Zalicus Pharmaceuticals, Ltd.. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Jeff T Gautschi: Innovator in Pharmaceutical Formulations
Introduction
Jeff T Gautschi is a notable inventor based in Bend, OR (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in enhancing the bioavailability of certain compounds. With a total of 2 patents to his name, Gautschi's work is recognized for its innovative approach to drug delivery systems.
Latest Patents
Gautschi's latest patents focus on solid dispersion formulations and methods of use thereof. The first patent relates to formulations and methods for increasing the bioavailability of 1-(4-benzhydrylpiperazin-1-yl)-3,3-diphenylpropan-1-one and 1-(3,3-diphenylpropanoyl)piperazine, or a salt thereof. This formulation can include one or more pharmaceutically acceptable matrix polymers to form a solid dispersion, such as a spray dried dispersion or a hot melt extrusion.
Career Highlights
Jeff T Gautschi is currently associated with Zalicus Pharmaceuticals, Ltd., where he continues to innovate in the pharmaceutical sector. His work is pivotal in developing new methods that enhance the effectiveness of drug formulations.
Collaborations
Some of his notable coworkers include Mahesh V Padval and Daniel Tod Smithey, who have collaborated with him on various projects within the pharmaceutical industry.
Conclusion
Jeff T Gautschi's contributions to pharmaceutical formulations demonstrate his commitment to improving drug delivery systems. His innovative patents and collaborations highlight his role as a key figure in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile